M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
Crossject secures EUR6.9m French government grant to advance ZENEO Epinephrine
Pharmaceutical company Crossject (Euronext Growth Paris:ALCJ) announced on Wednesday that it has received EUR6.9m in public funding from the French government's France 2030 plan to accelerate the development of its ZENEO Epinephrine auto-injector.
The funding, primarily grants with some...
If you want to view the full text of this story, you must first purchase archive credits. Return to Archives
New Search